← Open Payments lookup

CHELSEY BAKKER: Open Payments

NPI 1932818465 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,483 in 82 payments from 20 companies in 2025. Trend: 2023 $948 · 2024 $2,222 · 2025 $2,483

Food & beverage: $2,439Education: $42Travel & lodging: $2
CompanyPaymentsAmount
GENZYME CORPORATION19$570
AstraZeneca Pharmaceuticals LP11$553
Genentech USA, Inc.5$168
Novartis Pharmaceuticals Corporation6$157
Genentech, Inc.2$151
CSL Behring8$139
Blueprint Medicines Corporation1$122
Regeneron Healthcare Solutions, Inc.4$90
Takeda Pharmaceuticals U.S.A., Inc.3$77
Amgen Inc.3$76

Products named: DUPIXENT, Xolair, BEVESPI AEROSPHERE, FASENRA, TEZSPIRE, AYVAKIT, NEFFY, NEMLUVIO.

Industry payments across OK — which companies pay providers there.